"Creating an exceptional experience is at the center of what we do at Woman’s Hospital. From birth to mammography, from cancer care to surgery, we want to be your resource for exceptional care."

During the past decade, Woman's Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 34 clinical trials were completed, i.e. on average, 94.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 20 clinical trials were completed. i.e. 153.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woman's Hospital" #1 sponsor was "Gynecologic Oncology Group" with 16 trials, followed by "Woman's" with 14 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "GOG Foundation" with 9 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woman's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator and "Novo Nordisk A/S" with 3 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Woman's Hospital" are "Fallopian Tube Clear Cell Adenocarcinoma" (10 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (9 trials), "Fallopian Tube Transitional Cell Carcinoma" (9 trials), "Ovarian Clear Cell Adenocarcinoma" (9 trials) and "Primary Peritoneal Serous Adenocarcinoma" (9 trials). Many other conditions were trialed in "Woman's Hospital" in a lesser frequency.

Most popular intervention types in "Woman's Hospital" are "Drug" (49 trials), "Other" (38 trials), "Procedure" (18 trials), "Radiation" (14 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (23 trials), "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (20 trials), "Carboplatin" (15 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Woman's Hospital" are 59 trials for "Female" genders and 14 trials for "All" genders.

Currently, there are NaN active trials in "Woman's Hospital". undefined are not yet recruiting, 7 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Woman's Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Woman's Hospital, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 9 trials that are defined as “Not Applicable".